These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2648787

  • 1. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation.
    Connolly SJ, Hoffert DL.
    Am J Cardiol; 1989 Apr 01; 63(12):817-9. PubMed ID: 2648787
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E, Denjoy I.
    Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
    [Abstract] [Full Text] [Related]

  • 4. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
    Clin Cardiol; 1996 May 25; 19(5):409-12. PubMed ID: 8723601
    [Abstract] [Full Text] [Related]

  • 5. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
    Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Chen YJ, Yu WC, Huang JL, Fong AN, Cheng JJ, Chang MS.
    Am J Cardiol; 1997 Apr 01; 79(7):905-8. PubMed ID: 9104904
    [Abstract] [Full Text] [Related]

  • 6. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
    J Intern Med; 1996 Mar 01; 239(3):253-60. PubMed ID: 8772625
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 8. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP, Chow MS, Tse HF, Tang MO, Fan C.
    Am J Cardiol; 2000 Dec 15; 86(12):1327-32. PubMed ID: 11113407
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
    Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S, ERAFT Investigators.
    Am J Cardiol; 2002 Dec 15; 90(12):1300-6. PubMed ID: 12480038
    [Abstract] [Full Text] [Related]

  • 10. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
    Pritchett EL, Page RL, Carlson M, Undesser K, Fava G, Rythmol Atrial Fibrillation Trial (RAFT) Investigators.
    Am J Cardiol; 2003 Oct 15; 92(8):941-6. PubMed ID: 14556870
    [Abstract] [Full Text] [Related]

  • 12. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
    G Ital Cardiol; 1996 Apr 15; 26(4):379-90. PubMed ID: 8707022
    [Abstract] [Full Text] [Related]

  • 13. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F, Dabizzi RP, Cantini F, Natale MD, Niccoli L.
    Cardiovasc Drugs Ther; 1996 May 15; 10(2):153-7. PubMed ID: 8842507
    [Abstract] [Full Text] [Related]

  • 14. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R, Stiels B, Hoebrechts R.
    Am J Cardiol; 1997 Feb 15; 79(4):418-23. PubMed ID: 9052343
    [Abstract] [Full Text] [Related]

  • 15. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL, McCarthy EA, Wilkinson WE.
    Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
    [Abstract] [Full Text] [Related]

  • 16. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M, Cullen MT, Casadei G.
    Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
    [Abstract] [Full Text] [Related]

  • 17. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 25; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 18. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
    Kochiadakis GE, Igoumenidis NE, Hamilos MI, Tzerakis PG, Klapsinos NC, Zacharis EA, Vardas PE.
    Chest; 2004 Feb 25; 125(2):377-83. PubMed ID: 14769712
    [Abstract] [Full Text] [Related]

  • 19. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 25; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 20. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study.
    Azpitarte J, Alvarez M, Baún O, García R, Moreno E, Martín F, Tercedor L, Fernández R.
    Eur Heart J; 1997 Oct 25; 18(10):1649-54. PubMed ID: 9347277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.